Catalog Number
ACM28704270
IUPAC Name
(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid
Molecular Weight
563.6g/mol
Molecular Formula
C23H41N5O11
Canonical SMILES
CC(C(=O)O)N.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N
InChI
InChI=1S/C9H11NO3.C6H14N2O2.C5H9NO4.C3H7NO2/c10-8(9(12)13)5-6-1-3-7(11)4-2-6;7-4-2-1-3-5(8)6(9)10;6-3(5(9)10)1-2-4(7)8;1-2(4)3(5)6/h1-4,8,11H,5,10H2,(H,12,13);5H,1-4,7-8H2,(H,9,10);3H,1-2,6H2,(H,7,8)(H,9,10);2H,4H2,1H3,(H,5,6)/t8-;5-;3-;2-/m0000/s1
InChI Key
YLOCGHYTXIINAI-XKUOMLDTSA-N
Application
Poly(ala) is designed to mimic the structure and function of myelin basic protein (MBP) in order to modulate and suppress immune responses specifically related to myelin antigens. This polymer, created from a precise combination of amino acids, binds to MHC class II molecules, which helps it compete with myelin antigens for T-cell activation and induces the formation of specific Th2 suppressor cells. This antigen-specific action reduces the likelihood of long-term immune system damage by effectively inhibiting T-cell responses to MBP and other related antigens. The result is a significant reduction in relapse rates, particularly benefiting patients with minimal accumulated neurological disability.
Covalently-Bonded Unit Count
4
Exact Mass
563.280257g/mol
MeSH Entry Terms
5010, TV;Acetate, Glatiramer;Copaxone;Glatiramer;glatiramer acetate;TV 5010;TV-5010;TV5010;(L-tyrosine-L-glutamic acid)-poly(DL-alanine)-poly(L-lysine);(T,G)-A-L;(Tyr-Tyr-Glu-Glu)-poly(DL-Ala)-poly(Lys);Cop 1 (polymer);copolymer I (synthetic peptide);GLAT copolymer;multideterminant antigen (T,G)-A-L;poly-L-(Tyr,Glu)-poly-DL-Ala-poly-L-Lys;synthetic peptide copolymer I;TGAL copolymer
Monoisotopic Mass
563.280257g/mol